Submit your image related to Diseases to be featured!

Get Social

Submit your Twitter account related to Stage Iv Anal Canal Cancer to be featured!


Submit your blog on Stage Iv Anal Canal Cancer to be featured!


Submit your event on Stage Iv Anal Canal Cancer to be featured!


Submit your video on Stage Iv Anal Canal Cancer to be featured!


Submit your charity on Stage Iv Anal Canal Cancer to be featured!

Stage Iv Anal Canal Cancer: Disease Bioinformatics

Anal Cancer, or anal canal cancer, begins in the anus and is typically curable, however its specific location, size, and nodal status are large factors in its treatment. Anal Cancer is highly uncommon as it only accounts for 4% of all cancers of the lower alimentary track. Of the approximate 4,000 cases reported each year in the United States, around 85% of victims are Caucasian with an average age of 62. Individuals who have many sexual partners and may be exposed to the human papillomavirus (HPV) have a higher chance of being diagnosed with anal cancer as HPV is highly associated with the onset of anal cancer. Stage IV of anal canal cancer is characterized as when the cancer has spread to locations thoughout the body such as various organs, tissues, and lymph nodes without size limitations. Stage IV is considered to be the most aggressive stage of anal cancer.

Stage Iv Anal Canal Cancer Bioinformatics Tool

Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iv Anal Canal Cancer below! For more information on how to use Laverne, please read the How to Guide.
Vizit™, under license from BioVista Inc.

Top Research Reagents

We have 269 products for the study of Stage Iv Anal Canal Cancer that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.

Western Blot: RPS7 Antibody (3G4) [H00006201-M03] - Analysis of RPS7 expression in Raw 264.7 (Cat # L024V1).Immunocytochemistry/Immunofluorescence: RPS7 Antibody (3G4) [H00006201-M03] - Analysis of monoclonal antibody to RPS7 on HeLa cell. Antibody concentration 20 ug/ml

Mouse Monoclonal
Species Human, Mouse, Rat
Applications WB, ELISA, ICC/IF

Western Blot: Proteasome 19S S7 Antibody [NBP1-87797] - Lane 1: NIH-3T3 cell lysate (Mouse embryonic fibroblast cells)<br/>Lane 2: NBT-II cell lysate (Rat Wistar bladder tumour cells)Immunocytochemistry/Immunofluorescence: Proteasome 19S S7 Antibody [NBP1-87797] - Staining of human cell line U-2 OS shows positivity in nucleus but not nucleoli & cytoplasm.

Rabbit Polyclonal
Species Human, Mouse, Rat
Applications WB, ICC/IF, IHC

     1 Review

Western Blot: MS4A1/CD20 Antibody (AISB12) [NBP1-43435] - Immunoblot of Balb/c thymus (lane 1) and A20 (lane 2) cell lysates with Anti-Mouse CD20 Purified.Flow Cytometry: MS4A1/CD20 Antibody (AISB12) [NBP1-43435] - Staining of BALB/c splenocytes with Anti-Mouse CD19 Alexa Fluor (R) 647 and 1.0 micrograms conjugated anti-Mouse CD20 Purified followed by Anti-Rat IgG PE. Quadrant lines represent Rat IgG2a isotype control staining levels and cells in the lymphocyte gate were used for analysis.

Rat Monoclonal
Species Human, Mouse
Applications WB, Flow

3 Publications

Related Genes

Stage Iv Anal Canal Cancer has been researched against:

Related Pathways

Related PTMs

Alternate Names

Stage Iv Anal Canal Cancer is also known as Stage Iv Anal Cancer.